journal article·2022-06Open access

Hybrid membrane-camouflaged hollow prussian blue nanoparticles for shikonin loading and combined chemo/photothermal therapy of metastatic TNBC

Jiahao Liang, Chao Wang, Jialong Fan, Qian Xie, Zhenlong Yu, Bin Liu, Yan Tian, Jing Ning, Lei Feng, Wei Wang, Xiaochi Ma

Abstract

Triple-negative breast cancer (TNBC) metastasis is the cause of nearly 90% of breast cancer treatment failures as the side effects of clinical drugs and insufficient efficacy of single-modality therapy. Shikonin (SHK) is a naphthoquinone natural product from the herbal medicine Lithospermum erythrorhizon., which is widely used for cancer therapy as one kind of Chinese medicine for its significant anti-tumor, anti-metastatic, and anti-inflammatory effects. However, passive targeting of SHK to tumor location in vivo and long-term high dose administration is likely to decrease heart rate and induce drug resistance, which accordingly results in therapeutic failure. Thus, we designed a biomimetic SHK-loading nano-system (Hybrid [email protected]/[email protected]@SHK nanoparticles, HMGPHS NPs) to achieve controlled release and reduced SHK dosage. The prolonged circulation time and higher targeting of the HMGPHS NPs allowed less drug leakage systemically with increased drug concentration at the tumor sites compared to naked ICG/[email protected]@SHK (GPHS) NPs. Moreover, SHK could down-regulate the expression of COX-2, IL-6, and TNF-α to reduce the photothermal therapy-induced inflammatory response and improve the tumor microenvironment (TME), enabling HMGPHS NPs to significantly inhibit the growth and metastasis of TNBC. We propose that the combination of high efficacy, prolonged circulation, and high targeting of HMGPHS NPs could facilitate the conversion of SHK to clinical application for the effective treatment of TNBC.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Bioactive Compounds and Antitumor Agents · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Tumor metastasis: molecular insights and evolving paradigms10.1016/j.cell.2011.09.024 ↗
2. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies10.1016/S0140-6736(16)32454-0 ↗
3. Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review10.1007/s40262-017-0563-z ↗
4. Case Report: various abnormalities in lipid and glucose metabolism induced by capecitabine10.3389/fonc.2021.664475 ↗
5. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition10.1016/j.actbio.2020.06.025 ↗
6. Cell membrane camouflaged hollow prussian blue nanoparticles for synergistic photothermal-/chemotherapy of cancer10.1002/adfm.201605795 ↗
7. PEGylated WS2 nanodrug system with erythrocyte membrane coating for chemo/photothermal therapy of cervical cancer10.1039/D0BM00972E ↗
8. Cellular pharmacology studies of shikonin derivatives10.1002/ptr.1100 ↗
9. An ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells10.1016/j.canlet.2009.04.008 ↗
10. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells10.1021/jf4009586 ↗
11. Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition10.1016/j.ejphar.2011.02.043 ↗
12. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
13. Nanocarriers for cancer-targeted drug delivery10.3109/1061186X.2015.1051049 ↗
14. Combination therapy in combating cancer10.18632/oncotarget.16723 ↗
15. Dual mitigation of immunosuppression combined with photothermal inhibition for highly effective primary tumor and metastases therapy10.1016/j.biomaterials.2021.120856 ↗
16. A prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity10.1002/adma.201503381 ↗
17. Hyaluronic acid modified hollow prussian blue nanoparticles loading 10-hydroxycamptothecin for targeting thermochemotherapy of cancer10.7150/thno.13250 ↗
18. The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target10.1146/annurev-immunol-032713-120142 ↗
19. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer10.1016/j.biomaterials.2019.119301 ↗
20. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors10.1016/j.biomaterials.2018.11.021 ↗
21. Erythrocyte-Cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma10.1021/acsnano.7b08355 ↗
22. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer10.1039/C8NR10430A ↗
23. Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression10.1007/s10753-011-9299-3 ↗
24. A cytokine-mediated link between innate immunity, inflammation, and cancer10.1172/JCI31537 ↗
25. Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy10.1155/2016/2048731 ↗
26. Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species10.1038/srep38267 ↗
27. Nanoparticles for detection and diagnosis10.1016/j.addr.2009.11.004 ↗
28. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
29. Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo/photothermal therapy of cervical cancer and anti-inflammation10.1016/j.jconrel.2021.09.034 ↗
30. PB@PDA@Ag nanosystem for synergistically eradicating MRSA and accelerating diabetic wound healing assisted with laser irradiation10.1016/j.biomaterials.2020.119936 ↗
31. Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy10.1039/c2cc36456e ↗
32. Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser10.1016/0304-3835(95)03837-M ↗
33. Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies10.1016/j.biomaterials.2013.11.066 ↗
34. Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo10.1021/nn203293t ↗
35. A versatile gas-generator promoting drug release and oxygen replenishment for amplifying photodynamic-chemotherapy synergetic anti-tumor effects10.1016/j.biomaterials.2021.120985 ↗
36. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials10.1016/j.apsb.2016.01.007 ↗
37. 4T1 cell membrane fragment reunited PAMAM polymer units disguised as tumor cell clusters for tumor homotypic targeting and anti-metastasis treatment10.1039/D0BM01731K ↗
38. Regulated portals of entry into the cell10.1038/nature01451 ↗
39. Applications of surface modification technologies in nanomedicine for deep tumor penetration10.1002/advs.202002589 ↗
40. Precise regulation of inflammation and immunosuppressive microenvironment for amplified photothermal/immunotherapy against tumour recurrence and metastasis10.1016/j.nantod.2021.101266 ↗
41. Adapting and remolding: orchestrating tumor microenvironment normalization with photodynamic therapy by size transformable nanoframeworks10.1002/anie.202102180 ↗
42. A perspective on cancer cell metastasis10.1126/science.1203543 ↗
43. Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis10.3389/fonc.2018.00031 ↗
44. Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation10.3892/or.2014.3159 ↗
45. Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis10.1039/C8BM00381E ↗
46. Molecular mechanisms, characterization methods, and utilities of nanoparticle biotransformation in nanosafety assessments10.1002/smll.201907663 ↗